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ABSTRACT
Magnetic Resonance Imaging (MRI) has been gaining popularity in the clinic in recent years as a safe in-vivo
imaging technique. As a result, large troves of data are being gathered and stored daily that may be used as
clinical training sets in hospitals. While numerous machine learning (ML) algorithms have been implemented for
Alzheimer’s disease classiﬁcation, their outputs are usually diﬃcult to interpret in the clinical setting. Here, we
propose a simple method of rapid diagnostic classiﬁcation for the clinic using Support Vector Machines (SVM)1
and easy to obtain geometrical measurements that, together with a cortical and sub-cortical brain parcellation,
create a robust framework capable of automatic diagnosis with high accuracy. On a signiﬁcantly large imaging
dataset consisting of over 800 subjects taken from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
database, classiﬁcation-success indexes of up to 99.2% are reached with a single measurement.
Keywords: Alzheimer’s disease, machine learning, mild cognitive impairment, support vector machines, fast
clinical diagnosis.
1. INTRODUCTION
Magnetic Resonance Imaging is highly popular, and its growing use in the clinic is producing vast amounts of
data. This stored data is often diﬃcult to interpret visually, and, after the initial reading, does not currently
provide added clinical value other than as a retrospective reference for patients and clinicians. However, from
the perspective of machine learning, it could be the keystone for accelerating the diagnosis of diseases. Moreover,
machine learning methods can be applied to generate accurate prognosis, provided that a previous classiﬁcation
stage is accomplished with rigorousness. If a good experimental setup is accomplished, the accuracy of a machine
learning implementation increases with the number of independent features that it can learn from and the number
of training sets that it is fed. Conveniently, hospitals can provide a large source of data as training sets.
Here we present a machine learning - support vector machines design that is able to classify subjects into
Alzheimer’s disease, mild cognitive impairment and controls by limiting itself to four individual geometrical
measurements among 35 cortical regions in the brain. Our formulation is motivated by the real clinical scenario,
where the measurements have to be simple, intuitive and explainable. When a new subject is scanned, our
system labels it in one of three groups: Alzheimer’s disease, mild cognitive impairment or control, using previous
knowledge that exists intrinsically in the clinical database.
* equal senior author contribution
2. MATERIALS AND METHODS
Our dataset consists of 829 patients from the ADNI (adni.loni.usc.edu) database where subjects are classiﬁed
into three groups by well-established clinical diagnosis criteria: Alzheimer’s disease (AD), mild cognitive impair-
ment (MCI) and Controls (CTL) with 196, 406 and 228 subjects per group respectively. Using FreeSurfer,2, 3
measurements of structural thickness, contour area, volume and structural curvature are extracted in 35 regions
of the brain. For implementation purposes, these regions are labeled from 1 to 35.
The data is presented in comma separated values (CVS) ﬁles that are integrated in a Python numpy matrix.
This platform was chosen intentionally to comply with the Scikit-learn machine learning framework. The numpy
matrix is later queried using Python list comprehensions for data ﬁltering, segmentation, scaling and normal-
ization. The classiﬁers’ estimators are proved by cross correlation. The training and test samples are gathered
from the original dataset with a ratio of 0.8 : 0.2 (train:test) in a 6-fold experimental scheme. The scores and the
records of sensitivity and speciﬁcity are the mean values of the 6 experiments. With this data, three diﬀerent
setups are studied (see Sections 2.2, 2.3 and 2.4).
2.1 Exploring data patterns through principal component analysis and preliminary
experiments
Despite the fact that ML implementation proposed here has low dimensionality when compared with common
uses of ML algorithms, the 140 dimensions (see Section 2.4) are diﬃcult to represent for direct inspection and
classiﬁcation. Instead, we use a principal component analysis (PCA) to project points from a high n-dimensional
ﬁeld to a lower m-dimensional one. In our case, m = 2 is used for plotting purposes.
The PCA plots (see Figure 1), suggested a high degree of class separability when comparing AD with CTL
patients, while for the other possible groupings the distributions are more complex. We looked for quantitative
indexes of classiﬁcation through exploratory implementations of SVM using a linear kernel. These experiments
and their setups are explained below.
2.2 Approach A: mean value per region
The ﬁrst experimental approach consists of using the mean value per region of each geometrical factor as a
feature to see the inﬂuence of the geometrical factor in the classiﬁcation process and discover regions of high
diﬀerentiation. This setup results in a study matrix of n rows by 1 column. The experiment is run 12 times and
is the product of the four geometrical factors and the three pair of diagnosis groups among the pathologies. The
n values for these experiments are shown in the Section 3 on top of Tables 2 and 2.
2.3 Approach B: histogram
Here, we face a trade-oﬀ between accuracy and applicability. For high accuracy, it is possible to try a voxel-based
approach, but this requires time consuming computations that may reduce its value for the clinic. Alternatively,
in the last section, we computed a mean value of the geometrical factor per brain region, thus ML is easily
implementable; nevertheless the averaging function may smooth out some important diﬀerences. In order to
limit computational time while avoiding an excessive detail reduction, we decided to use a histogram approach
and create feature bins for our SVM implementation.
The dataset matrix results in n samples x 35 columns x number of bins. the 35 factor corresponds to the
number of regions studied in the brain, which is multiplied by the number of bins in the histogram. Here, we
limit ourselves to experiments for which we divide the data into 2 bins. The experiment above is repeated 12
times to test all the geometrical factors. The number of samples per diagnosis group (n), is given in Section 3
on top of tables 3 and 4.
2.4 Approach C: feature reduction and pathology linked brain regions
Improvement of the classiﬁcation indexes was done through dimension reduction using a K-best feature extrac-
tion. In addition to providing the best classifying geometrical factors, this method yields the cerebral regions
that are most useful for classiﬁcation.
The brain regions are selected by a feature reduction algorithm, that iteratively calculates the f value while
including region-by-region and factor-by-factor analyses. After each iteration, a SVM estimator is calculated
and a cross correlation experiment is run. The iteration that provides the highest score is selected along with
the regions and geometrical factors that best discriminate between the diagnoses. This setup results in a matrix
of n subjects x 35 brain regions x 4 geometric factors. The value n is the same one that was used in experiments
explained in Section 2.3 for each grouping test.
3. RESULTS
The high dimensionality reached when the four geometrical factors are combined with the 35 brain regions
analyzed make data trends diﬃcult to visualize. Instead, we use PCA to reduce the dimension of the dataset,
see Figure 1.
Figure 1: Principal Component Analysis. Frame A. AD vs. CTL. Frame B. AD vs. MCI. Frame C. MCI vs.
CTL.
Figure 1, panel A shows that a classifying algorithm using linear conditioning may create a separating
hyperplane which will accurately classify new subjects between the AD and CTL groups. As for the other two
groups, no linear boundaries are detected.
The resulting scores of an out-of-the-box linear SVM operating on the data including all the regions in all
subjects as samples and each geometrical factors (one-by-one) as features are shown in Tables 1 and 2.
AD vs. CTL (14840 samples) AD vs. MCI (21070 samples) MCI vs. CTL (22190 samples)
Th. Area. Vol. Curv. Th. Area. Vol. Curv. Th. Area. Vol. Curv.
57.3 55.1 55.5 53.9 67.4 67.2 67.5 67.9 64.0 64.3 64.0 63.8
s: 44.2 s: 68.6 s: 45.4 s: 51.5 s: 66.2 s: 70.6 s: 72.0 s: 55.9 s: 60.8 s: 52.7 s: 42.4 s: 65.6
e: 60.1 e: 61.5 e: 54.7 e: 50.1 e: 55.8 e: 65.6 e: 66.3 e: 58.1 e: 66.8 e: 59.2 e: 59.9 e: 56.7
Table 1: SVM scores in the left hemisphere (LH) for the mean value per region (see Section 2.2)
AD vs. CTL (14840 samples) AD vs. MCI (21070 samples) MCI vs. CTL (22190 samples)
Th. Area. Vol. Curv. Th. Area. Vol. Curv. Th. Area. Vol. Curv.
85.6 68.6 84.4 62.7 71.7 69.1 72.4 67.4 68.4 62.3 68.7 63.8
s: 92.4 s: 66.9 s: 91.4 s: 61.2 s: 78.3 s: 72.5 s: 80.9 s: 66.6 s: 72.7 s: 65.1 s: 69.1 s: 59.3
e: 81.7 e: 55.5 e: 82.3 e: 67.7 e: 71.4 e: 67.7 e: 72.6 e: 45.1 e: 71.1 e: 60.0 e: 55.9 e: 65.5
Table 2: SVM scores in the right hemisphere (RH) for the mean value per region (see Section 2.2)
The mean computation described in Section 2.2 yields low accuracy; the sensitivity (s) and speciﬁcity (e) are
low as well. We then look at the histograms as described in Section 2.3. The results of a 2-bins histogram setup
are shown in Tables 3 and 4.
AD vs.CTL (162 samples) AD vs. MCI (301 samples) MCI vs. CTL (317 samples)
Th. Area. Vol. Curv. Th. Area. Vol. Curv. Th. Area. Vol. Curv.
82.7 66.8 83.9 53.9 78.2 67.5 71.5 67.5 69.4 64.0 66.0 64.0
s: 82.8 s: 66.6 s: 81.8 s: 56.9 s: 77.4 s: 72.4 s: 75.0 s: 78.8 s: 73.8 s: 64.7 s: 75.0 s: 73.8
e: 88.3 e: 69.5 e: 83.6 e: 59.5 e: 75.9 e: 67.8 e: 71.6 e: 75.0 e: 58.9 e: 40.9 e: 52.9 e: 58.9
Table 3: SVM scores in the left hemisphere (LH) for the 2-bins histograms
AD vs. CTL (162 samples) AD vs. MCI (301 samples) MCI vs. CTL (317 samples)
Th. Area. Vol. Curv. Th. Area. Vol. Curv. Th. Area. Vol. Curv.
85.6 68.6 84.4 62.7 71.7 69.1 72.4 67.4 68.4 62.3 68.7 63.8
s: 92.4 s: 66.9 s: 91.4 s: 61.2 s: 78.3 s: 72.5 s: 80.9 s: 66.6 s: 72.7 s: 65.1 s: 69.1 s: 59.3
e: 81.7 e: 55.5 e: 82.3 e: 67.7 e: 71.4 e: 67.7 e: 72.6 e: 45.1 e: 71.1 e: 60.0 e: 55.9 e: 65.5
Table 4: SVM scores in the right hemisphere (RH) for the 2-bins histograms
For tables 1, 2, 3 and 4, Th stands for thickness, Vol for volume and Curv for curvature. The scores are
shown in percentile (%) values and represent the index of success of the algorithm at classifying the subjects.
While the indexes reported above are all over the guessing level, they are still too low for usability in the
clinic. Since neurological disorders do not aﬀect the brain uniformly, we design an experiment where a feature
reduction operation can discard brain regions while increasing the score of the estimator. Figure 2 depicts the
selected regions while Table 5 shows the scores obtained when the SVM algorithm works only in the reduced
dataset.
Figure 2: Cortical and sub-cortical brain regions with high impact when using SVM and geometrical factors for
automatic diagnosis. Frame A. AD vs CTL. Frame B. AD vs MCI. Frame C. MCI vs CTL. The top panel is an
adaptation of the Desikan Atlas4 used here for naming and positioning reference. The legend use primary colors
intentionally so the reader can infer in which regions a geometrical factor is relevant in stand alone fashion or by
combining it with another factor p.e: green refers to regions where blue and yellow coded factors act together,
brown deﬁnes a region where the three geometrical factors are relevant.
AD vs. CTL (162 Samples) AD vs. MCI (301 Samples) MCI vs. CTL (317 Samples)
LH 99.2 — s: 98.9 e: 97.8 86.3 — s: 90.1 e: 85.6 90.2 — s: 92.4 e: 89.6
RH 98.7 — s: 97.3 e: 98.0 88.3 — s: 92.4 e: 89.0 91.1 — s: 93.4 e: 90.4
Table 5: SVM scores in both hemispheres after applying the k-best feature reduction function
The values in Table 5 must be complemented with ﬁndings depicted in Figure 2. A well driven interpretation
must go as follows. The score in group AD vs. CTL in the left hemisphere is 98.7% when the colored regions
are used as factors together with the geometrical measurements that yields the color code used in the panel A
of Figure 2. Recall that the score is the result of averaging a 6-fold cross correlation experiment. A similar
reasoning must be used to interpret the scores in the other diagnostic pairs.
4. DISCUSSION
Machine learning (ML) is an outstanding tool for detecting patterns in high dimensional data sets such as the one
used here. The goal of this work was to provide a simple and fast detection tool to classify controls, MCI and AD
in the clinic. To do so, we used the well established Scikit-learn software, which avoids common ML problems
such as biasing or data variance. In the real clinical environment, a fast but accurate imaging measurement
is most useful as a ﬁrst step toward additional tests. So we restricted our results to some reliable but simple
imaging measurement as the features for the classiﬁcation. For all trials, the combination of thickness and volume
provided the two best discriminating measures.
From a purely numerical point-of-view, it is worth noting that the area is not included in Figure 2. This
is due to the fact that the area resulted in low sensitivity and was always selected out in the feature reduction
stage. With the remaining three factors and the 35 brain regions, we were able to automatically distinguish
between a healthy brain and one suﬀering from AD with a success index reaching 98.7% and 99.2% for the right
and left hemispheres respectively. This index is above the 85.7% index reported in5 and 82.8% in6 for the same
classiﬁcation. When trying to diﬀerentiate between AD and MCI brains, our best index reached 88.3%. This
classiﬁcation test was not done in,5 nor in.6 However,5 reported high accuracy in predicting MCI converters to
AD (86%), something that we have not explored yet with our approach. The authors in5 proposed a complex
weighted scheme in the whole brain that, in addition to the geometrical measurements, includes social factors as
features, something diﬃcult to assess in the clinic.
The results presented in this work are to be also compared with other techniques to distinguish between
diagnosis groups. With the increasing use of the MRI, many authors have proposed deterministic methods to
rapidly diagnose AD patients and predict MCI converters. Some of these references include,7 which used coronal
T1-weighted visual rating scales and yielded a 80 − 85% sensitivity and speciﬁcity to distinguish patients with
AD from those with no cognitive impairment (AD vs CTL group in this manuscript), and only slightly lower
sensitivity and speciﬁcity levels for diagnosing amnestic MCI. These scales also had good predictive power to
anticipate decline in MCI. Other authors have focused on speciﬁc brain regions and have associated physiological
facts that might help to increase the accuracy and the speed of automatic diagnosis tools. According to8 at the
mild dementia stage of AD, hippocampal volume is already reduced by 15 − 30% relative to controls, and in
the amnestic variant of MCI the volume is reduced by 10 − 15%. A recent meta-analysis estimated that medial
temporal atrophy has 73% sensitivity and 81% speciﬁcity for predicting whether patients with amnestic MCI will
convert to dementia.9 If medial temporal atrophy is measured with a continuous metric such as hippocampal
volume, speciﬁcity might be increased, but at the cost of reduced sensitivity.10
5. CONCLUSIONS
For any diagnostic marker to be useful in practice, its capacity to separate two or more conditions that can be
confused on clinical grounds is a necessary but not suﬃcient requirement. Clinical usefulness requires that the
marker provides beneﬁt over and above that provided by clinical assessment.10 Here, we present a method that
accomplish this. Moreover, the MRI acquisition system and the software used to recover the data here are useable
in research and in clinical settings, hence facilitating translation of our method from the former to the later.
Gathering information and interpreting it through machine learning methods opens not only the opportunity
to use sophisticated MRI analyses methods in the medical ﬁeld, but also to make health care institutions more
time eﬀective, hence improving patient care.
REFERENCES
[1] Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Prettenhofer,
P., Weiss, R., Dubourg, V., Vanderplas, J., Passos, A., Cournapeau, D., Brucher, M., Perrot, M., and
Duchesnay, E., “Scikit-learn: Machine learning in Python,” Journal of Machine Learning Research 12,
2825–2830 (2011).
[2] Fischl, B. and Dale, A., “Measuring the thickness of the human cerebral cortex from magnetic resonance
images,” Proceedings of the National Academy of Sciences of the United States of America 97(20), 11050–
11055 (2000).
[3] Han, X., j Jovicich, Salat, D., der Koewe, V., Quinn, B., Czanner, S., Busa, E., Pacheco, J., Albert M, K.,
Maguire, P., Rosas, D., Makris, N., Dale, A., Dickerson, B., and Fischl., B., “Reliability of MRI-derived
measurements of human cerebral cortical thickness: The eﬀects of ﬁeld strength, scanner upgrade and
manufacturer,” NeuroImage 32(1), 180–194 (2006).
[4] Desikan, R., SegonneÌĄ, F., Fischl, B., Quinn, B., Dickerson, B., Blacker, D., Buckner, R., Dale, A.,
Maguire, P., Hyman, B., Albert, M., and Killiany, R., “An automated labeling system for subdividing the
human cerebral cortex on mri scans into gyral based regions of interest,” NeuroImage 31(1), 968–80 (2006).
[5] Aguilar, C., Westman, E., Muehlboeck, S., Mecocci, P., Vellas, B., Tsolaki, M., Kloszewska, I., Soininen,
H., Lovestone, S., Spenger, C., Simmons, A., and Wahlund, L.-O., “Diﬀerent multivariate techniques for
automated classiﬁcation of mri data in alzheimer’s disease and mild cognitive impairment,”
[6] Cuingnet, R. et al., “Automatic classiﬁcation of patients with Alzheimer’s disease from struc tural MRI: A
comparison of ten methods using the ADNI database,” NeuroImage 56, 766 – 781 (15 May 2011).
[7] Scheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H., Vermersch, P., Kuiper, M., Steinling, M.,
Wolters, E. C., and Valk, J., “Atrophy of medial temporal lobes on mri in” probable” alzheimer’s disease and
normal ageing: diagnostic value and neuropsychological correlates.,” Journal of Neurology, Neurosurgery &
Psychiatry 55(10), 967–972 (1992).
[8] Shi, F., Liu, B., Zhou, Y., Yu, C., and Jiang, T., “Hippocampal volume and asymmetry in mild cognitive
impairment and alzheimer’s disease: Meta-analyses of mri studies,” Hippocampus 19(11), 1055–1064 (2009).
[9] Yuan, Y., Gu, Z.-X., and Wei, W.-S., “Fluorodeoxyglucose–positron-emission tomography, single-photon
emission tomography, and structural mr imaging for prediction of rapid conversion to alzheimer disease
in patients with mild cognitive impairment: a meta-analysis,” American Journal of Neuroradiology 30(2),
404–410 (2009).
[10] Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., and Thompson, P. M., “The clinical use of structural
mri in alzheimer disease,” Nature Reviews Neurology 6(2), 67–77 (2010).
